Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Susanne Saußele(University Hospital Heidelberg), Johan Richter(Skåne University Hospital), Joëlle Guilhot(Centre Hospitalier Universitaire de Poitiers), Franz Gruber(University Hospital of North Norway), Henrik Hjorth-Hansen(St Olav's University Hospital), António Almeida, Jeroen J. W. M. Janssen(Amsterdam UMC Location VUmc), Jiřı́ Mayer(Masaryk University), Perttu Koskenvesa(University of Helsinki), Panayiotis Panayiotidis(National and Kapodistrian University of Athens), Ulla Olsson‐Strömberg(Uppsala University Hospital), Joaquín Martínez‐López(Centro de Investigación Biomédica en Red de Cáncer), Philippe Rousselot(Université Paris-Saclay), Hanne Vestergaard(Odense University Hospital), Hans Ehrencrona(Lund University), Veli Kairisto(Turku University Hospital), Kateřina Machová Poláková(Institute of Haematology and Blood Transfusion), Martin C. Müller, Satu Mustjoki(University of Helsinki), Marc Berger(Université Clermont Auvergne), Alice Fabarius(University Hospital Heidelberg), Wolf‐Karsten Hofmann(University Hospital Heidelberg), Andreas Hochhaus(Jena University Hospital), Markus Pfirrmann(Ludwig-Maximilians-Universität München), François‐Xavier Mahon(Institut Bergonié), Gert J. Ossenkoppele, Maria Pagoni, Stina Söderlund, Martine Escoffre‐Barbe(Universidad Complutense de Madrid), Gabriel Étienne, Jolanta Dengler, Françoise Huguet, Nikolas von Bubnoff, Hana Klamová, Edgar Faber, François Guilhot(Inserm), Kourosh Lotfi, Delphine Réa(Jena University Hospital), Tim H. Brümmendorf, G.E. de Greef, Leif Stenke, Franck E. Nicolini, Laurence Legros, Andreas Burchert(Jena University Hospital), J Voglová, Aude Charbonnier, Emmanuel Gyan, Volker Kunzmann, Peter E. Westerweel
The Lancet Oncology
May 4, 2018
Cited by 607Open Access
Full Text

Abstract


Related Papers